We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Korn Ferry
KFY
$3.98B
| $816K | ﹤0.01% |
10,849
+2,814
| +35% | +$198K |
|
877
Sanmina
SANM
$11.2B
| $809K | ﹤0.01% |
11,816
+2,767
| +31% | +$191K |
|
|
PRFT
878
DELISTED
Perficient Inc
PRFT
| $807K | ﹤0.01% |
10,695
+1,823
| +21% | +$137K |
|
|
ALTM
879
DELISTED
Arcadium Lithium plc
ALTM
| $800K | ﹤0.01% |
280,723
+48,269
| +21% | +$140K |
|
880
COPT Defense Properties
CDP
$4.31B
| $794K | ﹤0.01% |
26,169
+5,752
| +28% | +$164K |
|
881
New York Times
NYT
$11.6B
| $793K | ﹤0.01% |
14,250
+6,538
| +85% | +$352K |
|
882
RXO
RXO
$4.23B
| $793K | ﹤0.01% |
28,325
+10,401
| +58% | +$294K |
|
883
Innovative Industrial Properties
IIPR
$1.78B
| $792K | ﹤0.01% |
5,883
+1,574
| +37% | +$192K |
|
884
Corcept Therapeutics
CORT
$10.2B
| $792K | ﹤0.01% |
17,107
+4,369
| +34% | +$155K |
|
885
News Corp Class B
NWS
$16.4B
| $790K | ﹤0.01% |
28,274
+12,583
| +80% | +$355K |
|
886
Newmark Group
NMRK
$2.73B
| $786K | ﹤0.01% |
50,622
+32,441
| +178% | +$421K |
|
|
SEM
887
DELISTED
Select Medical
SEM
| $786K | ﹤0.01% |
41,810
+12,004
| +40% | +$230K |
|
|
SQSP
888
DELISTED
Squarespace, Inc.
SQSP
| $785K | ﹤0.01% |
16,916
+3,656
| +28% | +$164K |
|
889
Frontdoor
FTDR
$5.02B
| $784K | ﹤0.01% |
16,338
+3,914
| +32% | +$170K |
|
890
Cedar Fair
FUN
$1.78B
| $781K | ﹤0.01% |
+19,367
| New | +$886K |
|
|
FOLD
891
DELISTED
Amicus Therapeutics
FOLD
| $779K | ﹤0.01% |
72,972
+15,811
| +28% | +$172K |
|
892
Oscar Health
OSCR
$8.5B
| $779K | ﹤0.01% |
36,742
+15,159
| +70% | +$273K |
|
|
HTLF
893
DELISTED
Heartland Financial USA, Inc.
HTLF
| $779K | ﹤0.01% |
13,740
+2,123
| +18% | +$111K |
|
894
Plexus
PLXS
$6.81B
| $776K | ﹤0.01% |
5,673
+1,446
| +34% | +$175K |
|
895
Texas Capital Bancshares
TCBI
$4.31B
| $770K | ﹤0.01% |
10,778
+2,243
| +26% | +$147K |
|
|
ESGR
896
DELISTED
Enstar Group
ESGR
| $770K | ﹤0.01% |
2,394
+795
| +50% | +$258K |
|
897
Avantor
AVTR
$7.81B
| $767K | ﹤0.01% |
+29,646
| New | +$728K |
|
898
Dyne Therapeutics
DYN
$4.04B
| $761K | ﹤0.01% |
21,182
+6,012
| +40% | +$239K |
|
899
Exelixis
EXEL
$13.9B
| $760K | ﹤0.01% |
29,292
-2,428
| -8% | -$60.3K |
|
900
Stride
LRN
$3.69B
| $758K | ﹤0.01% |
8,882
+2,399
| +37% | +$185K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.